Raymond James & Associates’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
Other funds holding BHC
IC
GAM
PC
IG
MMA
Raymond James & Associates's BHC Position: Q3 2024 in Review
Raymond James & Associates reduced its Bausch Health (BHC) stake by 23% in Q3 2024, selling an estimated $42.2K and leaving 21,253 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.
Raymond James & Associates first reported a position in BHC in Q3 2013 and has held it in 45 quarters since. The position peaked at $5.95M in Q2 2015. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.
- Raymond James & Associates held 21,253 shares of Bausch Health worth $173K as of Q3 2024.
- Raymond James & Associates sold 6,399 Bausch Health shares in Q3 2024, an estimated $42.2K.
- Bausch Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3683 holding.
- Raymond James & Associates first reported a position in Bausch Health in Q3 2013 and has held it in 45 quarters since.
- Raymond James & Associates's Bausch Health position peaked at $5.95M in Q2 2015.
- 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.